FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35026711000001109: Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Jan 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106148701000001114 Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106148801000001117 Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Is a Mebeverine 200mg modified-release capsules true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Is a Mebeverine hydrochloride 200mg m/r capsule false Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Has active ingredient Mebeverine hydrochloride true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Has manufactured dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Has specific active ingredient Mebeverine hydrochloride true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Has dispensed dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Is a Mebeverine 200mg modified-release capsules false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) 60 capsule 4 x 15 capsules Has AMP True Mebeverine 200mg modified-release capsules (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start